The availability of materials is a critical factor when it comes to vaccine capacity.
Jonathan Dakin
Advertisement
Jonathan Dakin is a collaborator with BioPlan Associates, Inc.
Articles by Jonathan Dakin
Advertisement
Latest Updated Articles
Supply Chain Challenges Creating Hurdles to COVID-19 Vaccine ProductionPublished: April 2nd 2021 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Everything to Know About Pharmaceutical Tariffs in 2025
2
Behind the Headlines Episode 28: Navigating FDA Shakeups and Obesity Drug Wars
3
Challenges for the Global Manufacturing of Vaccines
4
Building Resilience in Pharma: Our Top 10 Questions from CPHI Frankfurt
5
